Recent Updates
Recently added Catalysts
RMD Positive Sentiment

ResMed to Report Second Quarter Fiscal 2024 Earnings on January 24, 2024

Key Takeaway: ResMed announced it will release its financial and operational results for the second quarter of fiscal year 2024 on January 24, 2024, after market close. Following the release, a webcast will be hosted by management to discuss the results. ResMed highlights its role in pioneering innovative healthcare solutions and stresses its commitment to enhancing the quality of life for patients with chronic diseases through its digital health technologies.
Price reaction · baseline $171.78 (2024-01-02 close) · hit after-hours · clean, no other RMD news in the window
day 0 close · peak
-3.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • ResMed is set to announce its second quarter fiscal 2024 earnings, indicating continued business activity.
  • Management will host a webcast to discuss results, showcasing transparency and engagement with investors.
  • ResMed emphasizes innovation in healthcare solutions, indicating a strong commitment to improving quality of life.

Full Press Release Details

SAN DIEGO, Jan. 03, 2024 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the second quarter of fiscal year 2024 on Wednesday, January 24, 2024, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.
Earnings webcast details:
• Location: http://investor.resmed.com
• Date: Wednesday, January 24, 2024
• Time: 1:30 p.m. PST / 4:30 p.m. EST
• International: London, Wednesday, January 24, 2024, 9:30 p.m. GMT
Sydney, Thursday, January 25, 2024, 8:30 a.m. AEDT
Please note, ResMed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.
A replay of the earnings webcast will be accessible on ResMed’s website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from January 24, 2024, until February 7, 2024, at:
At ResMed (NYSE: RMD, ASX: RMD) we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with sleep apnea, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries. To learn more, visit ResMed.com and follow @ResMed.
For investors For media
+1 858.836.5000 +1 619.510.1281
investorrelations@resmed.com news@resmed.com

Frequently Asked Questions

When will ResMed release its Q2 fiscal 2024 results?

ResMed will release its Q2 fiscal 2024 results on January 24, 2024.

How can I access the ResMed earnings webcast?

The earnings webcast can be accessed at http://investor.resmed.com.

What is the time for the earnings call on January 24, 2024?

The earnings call is scheduled for 1:30 p.m. PST / 4:30 p.m. EST.

Will there be a replay of the earnings webcast?

Yes, a replay will be available approximately two hours after the webcast.

What does ResMed specialize in?

ResMed specializes in digital health technologies for chronic diseases.

Last updated: Jan 3, 2024